Stay updated on Nivolumab Relatlimab Advanced Chordoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page.

Latest updates to the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe change is a minor software revision from v3.4.1 to v3.4.2 and does not alter study content, eligibility criteria, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedMinor site version update from Revision: v3.4.0 to v3.4.1 with no visible changes to study content or page functionality.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check28 days agoChange DetectedGlossary and related terminology (including a Show glossary option and MeSH terms) were added, and a non-critical item ('No FEAR Act data') was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference55%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing v3.3.3. This is a minor metadata update and does not change study details.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a dedicated Locations section with California as a site and updated the page revision to v3.3.3. The old California Locations entry was removed and the HHS Vulnerability Disclosure footer link was deleted.SummaryDifference0.2%

- Check92 days agoChange DetectedFooter shows a site revision update from v3.2.0 to v3.3.2 (Revision: v3.3.2 now listed); no changes to trial content or page structure were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Relatlimab Advanced Chordoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page.